Approval · Notice of Compliance 2322 · 2001
AVONEX: Notice of Compliance 2322
Issued December 21, 2001
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2322
- Date
- December 21, 2001
- Company
- Biogen
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Alternate supplier for hsa as excipient
- Therapeutic class
- Immunodulator
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| AVONEX | Not yet assigned | — |
Medicinal ingredients
- INTERFERON BETA-1A 30 MCG per KIT